Request for Covid-19 Impact Assessment of this Report
Bioinformatics is the combination of information technology, statistics, molecular biology, and algorithms to analyze the data obtained from various experiments. It includes collecting biological data, preparation of a computational model, solving computational modeling problems, and evaluation of computational algorithm. Bioinformatics uses computation to extract knowledge from biological data, which can be used in drug discovery and developments.
The global bioinformatics market is expected to register substantial growth in the near future, owing to rise in need for integrated data and increase in applications of proteomics & genomics. In addition, drug discovery & development is expected to boost the market growth during the forecast period. However, lack of skilled personnel and common data formats is projected to hamper the market growth during the forecast period. Conversely, increase in need for integrated solutions & systems is expected to offer lucrative opportunities for market players.
The global bioinformatics market is segmented based on technology & services, application, sector, and region. By technology, the market is categorized into knowledge management tools, bioinformatics platforms, and bioinformatics services. Based on application, it is classified into metabolomics, molecular phylogenetics, transcriptomics, proteomics, chemoinformatics, genomics, and others. Depending on sector, it is segregated into medical bioinformatics, animal bioinformatics, agriculture bioinformatics, academics, and others. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
KEY BENEFITS FOR STAKEHOLDERS
This report provides a detailed quantitative analysis of the current market trends and future estimations from 2018 to 2025, which assists to identify the prevailing market opportunities.
An in-depth analysis of various regions is anticipated to provide a detailed understanding of the current trends to enable stakeholders to formulate region-specific plans.
A comprehensive analysis of the factors that drive and restrain the growth of the global bioinformatics market is provided.
KEY MARKET SEGMENTS
• By Technology & Services
o Knowledge Management Tools
Generalized Knowledge Management Tools
Specialized Knowledge Management Tools
o Bioinformatics Platforms
Sequence Analysis Platforms
Sequence Alignment Platforms
Sequence Manipulation Platforms
Structural Analysis Platforms
Others
o Bioinformatics Services
Sequencing Services
Database & Management
Data Analysis
Others
• By Application
o Metabolomics
o Molecular Phylogenetics
o Transcriptomics
o Proteomics
o Chemoinformatics
o Genomics
o Others
• By Sector
o Medical Bioinformatics
o Animal Bioinformatics
o Agriculture Bioinformatics
o Academics
o Others
• By Region
o North America
• U.S.
• Canada
• Mexico
o Europe
• Germany
• France
• UK
• Italy
• Sweden
• Rest of Europe
o Asia-Pacific
• Australia
• Japan
• India
• Vietnam
• Rest of Asia-Pacific
o LAMEA
• Nigeria
• Malawi
• Zambia
• Rest of LAMEA
KEY MARKET PLAYERS
• Agilent Technologies, Inc.
• Geneva Bioinformatics (Genebio)
• Dassault Systems
• Eurofins Scientific
• Illumina Inc.
• Bruker Daltonics Inc.
• Biomax Informatics AG
• Perkinelmer Inc.
• Qiagen N.V.
• Thermo Fisher Scientific, Inc.
The other players in the value chain include (profiles not included in the report):
• Accelrys, Inc.
• Affymetrix, Inc.
• SA Nonlinear Dynamics
• Quest Diagnostics, Inc.
1.1. Report description
1.2. Key benefits for stakeholders
1.3. Key market segments
1.4. Research methodology
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models
Chapter: 2: EXECUTIVE SUMMARY
2.1. CXO perspective
Chapter: 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top investment pockets
3.3. Top player positioning/ market share analysis 2017
3.4. Market dynamics
3.4.1. Drivers
3.4.1.1. Rise in need for integrated data
3.4.1.2. Increase in growth in proteomics & genomics
3.4.1.3. Drug discovery and development
3.4.2. Restraints
3.4.2.1. Lack of skilled personnel
3.4.2.2. Common data formats
3.4.3. Opportunity
3.4.3.1. Increase in need for integrated solutions & systems
3.5. Porter’s five forces analysis
3.6. Key Regulations
3.7. Value chain analysis
3.8. Bioinformatics in the drug development process
3.9. Patent analysis
3.10. Case studies
Chapter: 4: BIOINFORMATICS MARKET, BY TECHNOLOGY AND SERVICES
4.1. Overview
4.1.1. Market size and forecast
4.2. Knowledge Management Tools
4.2.1. Key market trends, growth factors, and opportunities
4.2.2. Market size and forecast, by type
4.2.2.1. Generalized knowledge management tools
4.2.2.1.1. Market size and forecast
4.2.2.2. Specialized knowledge management tools
4.2.2.2.1. Market size and forecast
4.2.3. Market size and forecast, by region
4.2.4. Market analysis, by country
4.3. Bioinformatics Platforms
4.3.1. Key market trends, growth factors, and opportunities
4.3.2. Market size and forecast, by type
4.3.2.1. Sequence analysis platforms
4.3.2.1.1. Market size and forecast
4.3.2.2. Sequence alignment platforms
4.3.2.2.1. Market size and forecast
4.3.2.3. Sequence manipulation platforms
4.3.2.3.1. Market size and forecast
4.3.2.4. Structural analysis platforms
4.3.2.4.1. Market size and forecast
4.3.2.5. Others
4.3.2.5.1. Market size and forecast
4.3.3. Market size and forecast, by region
4.3.4. Market analysis, by country
4.4. Bioinformatics Services
4.4.1. Key market trends, growth factors, and opportunities
4.4.2. Market size and forecast, by type
4.4.2.1. Sequencing services
4.4.2.1.1. Market size and forecast
4.4.2.2. Database and management
4.4.2.2.1. Market size and forecast
4.4.2.3. Data Analysis
4.4.2.3.1. Market size and forecast
4.4.2.4. Others
4.4.2.4.1. Market size and forecast
4.4.3. Market size and forecast, by region
4.4.4. Market analysis, by country
Chapter: 5: BIOINFORMATICS MARKET, BY APPLICATION
5.1. Overview
5.1.1. Market size and forecast, by region
5.2. Genomics
5.2.1. Metagenomics
5.2.2. Population genomics
5.2.3. Market size and forecast, by region
5.2.4. Market analysis, by country
5.3. Chemoinformatics and Drug Design
5.3.1. Market Size and Forecast, By Region
5.3.2. Market analysis, by country
5.4. Proteomics
5.4.1. Market Size and Forecast, by region
5.4.2. Market analysis, by country
5.5. Transcriptomics
5.5.1. Market size and forecast
5.5.2. Market analysis, by country
5.6. Metabolomics
5.6.1. Market size and forecast
5.6.2. Market analysis, by country
5.7. Molecular Phylogenetics
5.7.1. Market size and forecast
5.7.2. Market analysis, by country
5.8. Other application market
5.8.1. Pharmacogenomics
5.8.2. Pharmacoproteomics
5.8.2.1. Market size and forecast
5.8.3. Market analysis, by country
Chapter: 6: GLOBAL BIOINFORMATICS MARKET BY SECTOR
6.1. Overview
6.1.1. Market size and forecast, by region
6.2. Medical bioinformatics
6.2.1. Drug development
6.2.2. Molecular medicine
6.2.3. Preventive medicine
6.2.4. Gene therapy
6.2.5. Market size and forecast, by region
6.2.6. Market analysis, by country
6.3. Animal Bioinformatics
6.3.1. Market size and forecast, by region
6.3.2. Market analysis, by country
6.4. Agricultural bioinformatics
6.4.1. Crop yield improvement
6.4.2. Pest resistance
6.4.3. Plant resistance against abiotic stresses
6.4.4. Improve nutritional quality
6.4.5. Market size and forecast by region
6.4.6. Market analysis, by country
6.5. Academics
6.5.1. Market size and forecast, by region
6.5.2. Market analysis, by country
6.6. Others (Microbial genome)
6.6.1. Market size and forecast, by region
6.6.2. Market analysis, by country
Chapter: 7: BIOINFORMATICS MARKET, BY REGION
7.1. OVERVIEW
7.1.1. Market size and forecast
7.2. North America
7.2.1. Key market trends and opportunities
7.2.2. North America bioinformatics market, by country
7.2.2.1. U.S. bioinformatics market, by technology and services
7.2.2.2. U.S. bioinformatics market, by application
7.2.2.3. U.S. bioinformatics market, by sector
7.2.2.4. Canada bioinformatics market, by technology and services
7.2.2.5. Canada bioinformatics market, by Application
7.2.2.6. Canada bioinformatics market, by sector
7.2.2.7. Mexico bioinformatics market, by technology and services
7.2.2.8. Mexico bioinformatics market, by application
7.2.2.9. Mexico bioinformatics market, by sector
7.2.3. North America bioinformatics market, by technology and services
7.2.4. North America bioinformatics market, by Application
7.2.5. North America bioinformatics market, by Sector
7.3. Europe
7.3.1. Key market trends and opportunities
7.3.2. Europe bioinformatics market, by country
7.3.2.1. Germany bioinformatics market, by technology and services
7.3.2.2. Germany bioinformatics market, by application
7.3.2.3. Germany bioinformatics market, by sector
7.3.2.4. France bioinformatics market, by technology and services
7.3.2.5. France bioinformatics market, by application
7.3.2.6. France bioinformatics market, by sector
7.3.2.7. UK bioinformatics market, by technology and services
7.3.2.8. UK bioinformatics market, by application
7.3.2.9. UK bioinformatics market, by sector
7.3.2.10. Italy bioinformatics market, by technology and services
7.3.2.11. Italy bioinformatics market, by application
7.3.2.12. Italy bioinformatics market, by sector
7.3.2.13. Spain bioinformatics market, by technology and services
7.3.2.14. Spain bioinformatics market, by application
7.3.2.15. Spain bioinformatics market, by sector
7.3.2.16. Rest of Europe bioinformatics market, by technology and services
7.3.2.17. Rest of Europe bioinformatics market, by application
7.3.2.18. Rest of Europe bioinformatics market, by sector
7.3.3. Europe bioinformatics market, by technology and services
7.3.4. Europe bioinformatics market, by application
7.3.5. Europe bioinformatics market, by sector
7.4. Asia-Pacific
7.4.1. Key market trends and opportunities
7.4.2. Asia-Pacific bioinformatics market, by country
7.4.2.1. Japan bioinformatics market, by technology and services
7.4.2.2. Japan bioinformatics market, by Application
7.4.2.3. Japan bioinformatics market, by sector
7.4.2.4. China bioinformatics market, by technology and services
7.4.2.5. China bioinformatics market, by application
7.4.2.6. China bioinformatics market, by sector
7.4.2.7. India bioinformatics market, by technology and services
7.4.2.8. India bioinformatics market, by application
7.4.2.9. India bioinformatics market, by sector
7.4.2.10. Australia bioinformatics market, by technology and services
7.4.2.11. Australia bioinformatics market, by application
7.4.2.12. Australia bioinformatics market, by sector
7.4.2.13. South Korea bioinformatics market, by technology and services
7.4.2.14. South Korea bioinformatics market, by application
7.4.2.15. South Korea bioinformatics market, by sector
7.4.2.16. Taiwan bioinformatics market, by technology and services
7.4.2.17. Taiwan bioinformatics market, by Application
7.4.2.18. Taiwan bioinformatics market, by sector
7.4.2.19. Rest of Asia-Pacific bioinformatics market, by technology and services
7.4.2.20. Rest of Asia-Pacific bioinformatics market, by application
7.4.2.21. Rest of Asia-Pacific bioinformatics market, by sector
7.4.3. Asia-Pacific bioinformatics market, by technology and services
7.4.4. Asia-Pacific bioinformatics market, by application
7.4.5. Asia-Pacific bioinformatics market, by sector
7.5. LAMEA
7.5.1. Key market trends and opportunities
7.5.2. LAMEA bioinformatics market, by country
7.5.2.1. Brazil bioinformatics market, by technology and services
7.5.2.2. Brazil bioinformatics market, by application
7.5.2.3. Brazil bioinformatics market, by sector
7.5.2.4. Saudi Arabia bioinformatics market, by technology and services
7.5.2.5. Saudi Arabia bioinformatics market, by application
7.5.2.6. Saudi Arabia bioinformatics market, by sector
7.5.2.7. South Africa bioinformatics market, by technology and services
7.5.2.8. South Africa bioinformatics market, by application
7.5.2.9. South Africa bioinformatics market, by sector
7.5.2.10. Rest of LAMEA bioinformatics market, by technology and services
7.5.2.11. Rest of LAMEA bioinformatics market, by application
7.5.2.12. Rest of LAMEA bioinformatics market, by sector
7.5.3. LAMEA bioinformatics market, by technology and services
7.5.4. LAMEA bioinformatics market, by application
7.5.5. LAMEA bioinformatics market, by sector
Chapter: 8: COMPANY PROFILES
8.1. AGILENT TECHNOLOGIES, INC.
8.1.1. Company overview
8.1.2. Company snapshot
8.1.3. Operating business segments
8.1.4. Product portfolio
8.1.5. Business performance
8.1.6. Key strategic moves and developments
8.2. BIOMAX INFORMATICS AG
8.2.1. Company overview
8.2.2. Company snapshot
8.2.3. Operating business segments
8.2.4. Product Portfolio
8.2.5. Key strategic moves and developments
8.3. BRUKER CORPORATION
8.3.1. Company overview
8.3.2. Company snapshot
8.3.3. Operating business segments
8.3.4. Product portfolio
8.3.5. Business performance
8.3.6. Key strategic moves and developments
8.4. DASSAULT SYSTEMES
8.4.1. Company overview
8.4.2. Company snapshot
8.4.3. Operating business segments
8.4.4. Product Portfolio
8.4.5. Business performance
8.5. EUROFINS SCIENTIFIC
8.5.1. Company overview
8.5.2. Company snapshot
8.5.3. Product portfolio
8.5.4. Business performance
8.6. GENEVA BIOINFORMATICS (GENEBIO) S.A.
8.6.1. Company overview
8.6.2. Company snapshot
8.6.3. Operating business segments
8.6.4. Product portfolio
8.7. ILLUMINA, INC.
8.7.1. Company overview
8.7.2. Company snapshot
8.7.3. Operating business segments
8.7.4. Product portfolio
8.7.5. Business performance
8.7.6. Key strategic moves and developments
8.8. PERKINELMER INC.
8.8.1. Company overview
8.8.2. Company snapshot
8.8.3. Operating business segments
8.8.4. Product portfolio
8.8.5. Business performance
8.8.6. Key strategic moves and developments
8.9. QIAGEN N.V.
8.9.1. Company overview
8.9.2. Company snapshot
8.9.3. Product portfolio
8.9.4. Business performance
8.9.5. Key strategic moves and developments
8.10. THERMO FISHER SCIENTIFIC, INC.
8.10.1. Company overview
8.10.2. Company snapshot
8.10.3. Operating business segments
8.10.4. Product portfolio
8.10.5. Business performance
8.10.6. Key strategic moves and developments
TABLE 01. GLOBAL BIOINFORMATICS MARKET, BY TECHNOLOGY AND SERVICES, 2017–2025 ($MILLION)
TABLE 02. BIOINFORMATICS MARKET FOR KNOWLEDGE MANAGEMENT TOOLS, BY TYPE, 2017–2025 ($MILLION)
TABLE 03. BIOINFORMATICS MARKET FOR KNOWLEDGE MANAGEMENT TOOLS, BY REGION, 2017–2025 ($MILLION)
TABLE 04. BIOINFORMATICS MARKET FOR BIOINFORMATICS PLATFORMS, BY TYPE, 2017–2025 ($MILLION)
TABLE 05. BIOINFORMATICS MARKET FOR BIOINFORMATICS PLATFORMS, BY REGION, 2017–2025 ($MILLION)
TABLE 06. BIOINFORMATICS MARKET FOR BIOINFORMATICS SERVICES, BY TYPE, 2017–2025 ($MILLION)
TABLE 07. BIOINFORMATICS SERVICES MARKET, BY REGION, 2017–2025 ($MILLION)
TABLE 08. GLOBAL BIOINFORMATICS MARKET, BY APPLICATION 2017-2025($MILLION)
TABLE 09. GLOBAL BIOINFORMATICS MARKET FOR GENOMICS, BY REGION 2017-2025 ($MILLION)
TABLE 10. BIOINFORMATICS MARKET FOR CHEMOINFORMATICS AND DRUG DESIGN, BY REGION 2017-2025 ($MILLION)
TABLE 11. BIOINFORMATICS MARKET FOR PROTEOMICS, BY REGION 2013-2020 ($MILLION)
TABLE 12. BIOINFORMATICS MARKET FOR TRANSCRIPTOMICS, BY REGION 2013-2020 ($MILLION)
TABLE 13. BIOINFORMATICS MARKET FOR METABOLOMICS, BY REGION 2013 – 2020 ($MILLION)
TABLE 14. BIOINFORMATICS MARKET FOR MOLECULAR PHYLOGENETICS, BY REGION 2013-2020 ($MILLION)
TABLE 15. BIOINFORMATICS MARKET FOR OTHER APPLICATION, BY REGION 2013 – 2020 ($MILLION)
TABLE 16. GLOBAL BIOINFORMATICS MARKET BY SECTOR, 2017-2025($MILLION)
TABLE 17. MEDICAL BIOINFORMATICS SECTOR MARKET, BY REGION 2017-2025 ($MILLION)
TABLE 18. ANIMAL BIOINFORMATICS SECTOR MARKET, BY REGION 2017-2025 ($MILLION)
TABLE 19. AGRICULTURE BIOINFORMATICS SECTOR MARKET, BY REGION 2017-2025 ($MILLION)
TABLE 20. GLOBAL BIOINFORMATICS ACADEMICS MARKET, BY REGION 2017-2025 ($MILLION)
TABLE 21. BIOINFORMATICS MARKET FOR OTHERS SECTORS, BY REGION 2017-2025 ($MILLION)
TABLE 22. BIOINFORMATICS MARKET REVENUE, BY REGION, 2017–2025 ($MILLION)
TABLE 23. NORTH AMERICA BIOINFORMATICS MARKET, BY COUNTRY, 2017–2025 ($MILLION)
TABLE 24. U.S. BIOINFORMATICS MARKET, BY TECHNOLOGY AND SERVICES, 2017–2025 ($MILLION)
TABLE 25. U.S. BIOINFORMATICS MARKET, BY APPLICATION, 2017–2025 ($MILLION)
TABLE 26. U.S. BIOINFORMATICS MARKET, BY SECTOR, 2017–2025 ($MILLION)
TABLE 27. CANADA BIOINFORMATICS MARKET, BY TECHNOLOGY AND SERVICES, 2017–2025 ($MILLION)
TABLE 28. CANADA BIOINFORMATICS MARKET, BY APPLICATION, 2017–2025 ($MILLION)
TABLE 29. CANADA BIOINFORMATICS MARKET, BY SECTOR, 2017–2025 ($MILLION)
TABLE 30. MEXICO BIOINFORMATICS MARKET, BY TECHNOLOGY AND SERVICES, 2017–2025 ($MILLION)
TABLE 31. MEXICO BIOINFORMATICS MARKET, BY APPLICATION, 2017–2025 ($MILLION)
TABLE 32. MEXICO BIOINFORMATICS MARKET, BY SECTOR, 2017–2025 ($MILLION)
TABLE 33. NORTH AMERICA BIOINFORMATICS MARKET, BY TECHNOLOGY AND SERVICES, 2017–2025 ($MILLION)
TABLE 34. NORTH AMERICA BIOINFORMATICS MARKET, BY APPLICATION, 2017–2025 ($MILLION)
TABLE 35. NORTH AMERICA BIOINFORMATICS MARKET, BY SECTOR, 2017–2025 ($MILLION)
TABLE 36. EUROPE BIOINFORMATICS MARKET, BY COUNTRY, 2017–2025 ($MILLION)
TABLE 37. GERMANY BIOINFORMATICS MARKET, BY TECHNOLOGY AND SERVICES, 2017–2025 ($MILLION)
TABLE 38. GERMANY BIOINFORMATICS MARKET, BY APPLICATION, 2017–2025 ($MILLION)
TABLE 39. GERMANY BIOINFORMATICS MARKET, BY SECTOR, 2017–2025 ($MILLION)
TABLE 40. FRANCE BIOINFORMATICS MARKET, BY TECHNOLOGY AND SERVICES, 2017–2025 ($MILLION)
TABLE 41. FRANCE BIOINFORMATICS MARKET, BY APPLICATION, 2017–2025 ($MILLION)
TABLE 42. FRANCE BIOINFORMATICS MARKET, BY SECTOR, 2017–2025 ($MILLION)
TABLE 43. UK BIOINFORMATICS MARKET, BY TECHNOLOGY AND SERVICES, 2017–2025 ($MILLION)
TABLE 44. UK BIOINFORMATICS MARKET, BY APPLICATION, 2017–2025 ($MILLION)
TABLE 45. UK BIOINFORMATICS MARKET, BY SECTOR, 2017–2025 ($MILLION)
TABLE 46. ITALY BIOINFORMATICS MARKET, BY TECHNOLOGY AND SERVICES, 2017–2025 ($MILLION)
TABLE 47. ITALY BIOINFORMATICS MARKET, BY APPLICATION, 2017–2025 ($MILLION)
TABLE 48. ITALY BIOINFORMATICS MARKET, BY SECTOR, 2017–2025 ($MILLION)
TABLE 49. SPAIN BIOINFORMATICS MARKET, BY TECHNOLOGY AND SERVICES, 2017–2025 ($MILLION)
TABLE 50. SPAIN BIOINFORMATICS MARKET, BY APPLICATION, 2017–2025 ($MILLION)
TABLE 51. SPAIN BIOINFORMATICS MARKET, BY SECTOR, 2017–2025 ($MILLION)
TABLE 52. REST OF EUROPE BIOINFORMATICS MARKET, BY TECHNOLOGY AND SERVICES, 2017–2025 ($MILLION)
TABLE 53. REST OF EUROPE BIOINFORMATICS MARKET, BY APPLICATION, 2017–2025 ($MILLION)
TABLE 54. REST OF EUROPE BIOINFORMATICS MARKET, BY SECTOR, 2017–2025 ($MILLION)
TABLE 55. EUROPE BIOINFORMATICS MARKET, BY TECHNOLOGY AND SERVICES, 2017–2025 ($MILLION)
TABLE 56. EUROPE BIOINFORMATICS MARKET, BY APPLICATION, 2017–2025 ($MILLION)
TABLE 57. EUROPE BIOINFORMATICS MARKET, BY SECTOR, 2017–2025 ($MILLION)
TABLE 58. ASIA-PACIFIC BIOINFORMATICS MARKET, BY COUNTRY, 2017–2025 ($MILLION)
TABLE 59. JAPAN BIOINFORMATICS MARKET, BY TECHNOLOGY AND SERVICES, 2017–2025 ($MILLION)
TABLE 60. JAPAN BIOINFORMATICS MARKET, BY APPLICATION, 2017–2025 ($MILLION)
TABLE 61. JAPAN BIOINFORMATICS MARKET, BY SECTOR, 2017–2025 ($MILLION)
TABLE 62. CHINA BIOINFORMATICS MARKET, BY TECHNOLOGY AND SERVICES, 2017–2025 ($MILLION)
TABLE 63. CHINA BIOINFORMATICS MARKET, BY APPLICATION, 2017–2025 ($MILLION)
TABLE 64. CHINA BIOINFORMATICS MARKET, BY SECTOR, 2017–2025 ($MILLION)
TABLE 65. INDIA BIOINFORMATICS MARKET, BY TECHNOLOGY AND SERVICES, 2017–2025 ($MILLION)
TABLE 66. INDIA BIOINFORMATICS MARKET, BY APPLICATION, 2017–2025 ($MILLION)
TABLE 67. INDIA BIOINFORMATICS MARKET, BY SECTOR, 2017–2025 ($MILLION)
TABLE 68. AUSTRALIA BIOINFORMATICS MARKET, BY TECHNOLOGY AND SERVICES, 2017–2025 ($MILLION)
TABLE 69. AUSTRALIA BIOINFORMATICS MARKET, BY APPLICATION, 2017–2025 ($MILLION)
TABLE 70. AUSTRALIA BIOINFORMATICS MARKET, BY SECTOR, 2017–2025 ($MILLION)
TABLE 71. SOUTH KOREA BIOINFORMATICS MARKET, BY TECHNOLOGY AND SERVICES, 2017–2025 ($MILLION)
TABLE 72. SOUTH KOREA BIOINFORMATICS MARKET, BY APPLICATION, 2017–2025 ($MILLION)
TABLE 73. SOUTH KOREA BIOINFORMATICS MARKET, BY SECTOR, 2017–2025 ($MILLION)
TABLE 74. TAIWAN BIOINFORMATICS MARKET, BY TECHNOLOGY AND SERVICES, 2017–2025 ($MILLION)
TABLE 75. TAIWAN BIOINFORMATICS MARKET, BY TYPE, 2017–2025 ($MILLION)
TABLE 76. TAIWAN BIOINFORMATICS MARKET, BY APPLICATION, 2017–2025 ($MILLION)
TABLE 77. REST OF ASIA-PACIFIC BIOINFORMATICS MARKET, BY TECHNOLOGY AND SERVICES, 2017–2025 ($MILLION)
TABLE 78. REST OF ASIA-PACIFIC BIOINFORMATICS MARKET, BY APPLICATION, 2017–2025 ($MILLION)
TABLE 79. REST OF ASIA-PACIFIC BIOINFORMATICS MARKET, BY SECTOR, 2017–2025 ($MILLION)
TABLE 80. ASIA-PACIFIC BIOINFORMATICS MARKET, BY TECHNOLOGY AND SERVICES, 2017–2025 ($MILLION)
TABLE 81. ASIA-PACIFIC BIOINFORMATICS MARKET, BY APPLICATION, 2017–2025 ($MILLION)
TABLE 82. ASIA-PACIFIC BIOINFORMATICS MARKET, BY SECTOR, 2017–2025 ($MILLION)
TABLE 83. LAMEA BIOINFORMATICS MARKET, BY COUNTRY, 2017–2025 ($MILLION)
TABLE 84. BRAZIL BIOINFORMATICS MARKET, BY TECHNOLOGY AND SERVICES, 2017–2025 ($MILLION)
TABLE 85. BRAZIL BIOINFORMATICS MARKET, BY APPLICATION, 2017–2025 ($MILLION)
TABLE 86. BRAZIL BIOINFORMATICS MARKET, BY SECTOR, 2017–2025 ($MILLION)
TABLE 87. SAUDI ARABIA BIOINFORMATICS MARKET, BY TECHNOLOGY AND SERVICES, 2017–2025 ($MILLION)
TABLE 88. SAUDI ARABIA BIOINFORMATICS MARKET, BY APPLICATION, 2017–2025 ($MILLION)
TABLE 89. SAUDI ARABIA BIOINFORMATICS MARKET, BY SECTOR, 2017–2025 ($MILLION)
TABLE 90. SOUTH AFRICA BIOINFORMATICS MARKET, BY TECHNOLOGY AND SERVICES, 2017–2025 ($MILLION)
TABLE 91. SOUTH AFRICA BIOINFORMATICS MARKET, BY APPLICATION, 2017–2025 ($MILLION)
TABLE 92. SOUTH AFRICA BIOINFORMATICS MARKET, BY SECTOR, 2017–2025 ($MILLION)
TABLE 93. REST OF LAMEA BIOINFORMATICS MARKET, BY TECHNOLOGY AND SERVICES, 2017–2025 ($MILLION)
TABLE 94. REST OF LAMEA BIOINFORMATICS MARKET, BY APPLICATION, 2017–2025 ($MILLION)
TABLE 95. REST OF LAMEA BIOINFORMATICS MARKET, BY SECTOR, 2017–2025 ($MILLION)
TABLE 96. LAMEA BIOINFORMATICS MARKET, BY TECHNOLOGY AND SERVICES, 2017–2025 ($MILLION)
TABLE 97. LAMEA BIOINFORMATICS MARKET, BY APPLICATION, 2017–2025 ($MILLION)
TABLE 98. LAMEA BIOINFORMATICS MARKET, BY SECTOR, 2017–2025 ($MILLION)
TABLE 99. AGILENT: COMPANY SNAPSHOT
TABLE 100. AGILENT: OPERATING SEGMENTS
TABLE 101. AGILENT: PRODUCT PORTFOLIO
TABLE 102. BIOMAX INFORMATICS AG.: COMPANY SNAPSHOT
TABLE 103. BIOMAX INFORMATICS AG.: OPERATING SEGMENTS
TABLE 104. BIOMAX INFORMATICS AG.: PRODUCT PORTFOLIO
TABLE 105. BRUKER CORPORATION: COMPANY SNAPSHOT
TABLE 106. BRUKER CORPORATION: OPERATING SEGMENTS
TABLE 107. BRUKER CORPORATION: PRODUCT PORTFOLIO
TABLE 108. DASSAULT SYSTEMES: COMPANY SNAPSHOT
TABLE 109. DASSAULT SYSTEMES: OPERATING SEGMENTS
TABLE 110. DASSAULT SYSTEMES: PRODUCT PORTFOLIO
TABLE 111. EUROFINS SCIENTIFIC: COMPANY SNAPSHOT
TABLE 112. EUROFINS SCIENTIFIC.: PRODUCT PORTFOLIO
TABLE 113. GENEVA BIOINFORMATICS (GENEBIO) SA: COMPANY SNAPSHOT
TABLE 114. GENEVA BIOINFORMATICS (GENEBIO) SA: OPERATING SEGMENTS
TABLE 115. GENEVA BIOINFORMATICS (GENEBIO) SA: PRODUCT PORTFOLIO
TABLE 116. ILLUMINA: COMPANY SNAPSHOT
TABLE 117. ILLUMINA: OPERATING SEGMENTS
TABLE 118. ILLUMINA: PRODUCT PORTFOLIO
TABLE 119. PERKINELMER: COMPANY SNAPSHOT
TABLE 120. PERKINELMER: OPERATING SEGMENTS
TABLE 121. PERKINELMER: PRODUCT PORTFOLIO
TABLE 122. QIAGEN: COMPANY SNAPSHOT
TABLE 123. QIAGEN: PRODUCT PORTFOLIO
TABLE 124. THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT
TABLE 125. THERMO FISHER SCIENTIFIC: OPERATING SEGMENTS
TABLE 126. THERMO FISHER SCIENTIFIC: PRODUCT PORTFOLIO
Medical implants are permanent devices such as pacemakers or temporary devices such as fracture plates which are removed once their function is completed. These implants are made up of bone, tissue, skin, ceramics, metals, plastics, and other natural materials...
Ostomy is a surgery wherein an artificial opening, known as stoma, is created from the colon in the human body to eliminate body wastes such as urine, mucus, and stools, which are collected in artificial bags called ostomy drainage bags. These plastic/rub...
Laparoscopy is a minimally invasive procedure used to examine organs inside the abdomen or pelvic cavities by inserting a laparoscope through a small incision in the abdomen. A laparoscope comprises a long, thin tube with high-intensity light, and high-re...